A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression

A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression

In the absence of head-to-head trials of first-line treatments for metastatic non-small cell lung cancer (NSCLC), synthesis of available evidence is needed. We conducted a systematic literature review and network meta-analysis of randomized controlled trials in patients with stage IV NSCLC and high...

Full description

Bibliographic Details
Main Authors: Roy Herbst, Jacek Jassem, Seye Abogunrin, Daniel James, Rachael McCool, Rossella Belleli, Giuseppe Giaccone, Filippo De Marinis
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
immunotherapy
atezolizumab
pembrolizumab
nivolumab
ipilimumab
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.676732/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.676732/full

Similar Items